TLDR IonQ stock jumped 10.9% on Monday with no clear news catalyst driving the rally The quantum computing company trades at 2,293 times sales with just $7.5 millionTLDR IonQ stock jumped 10.9% on Monday with no clear news catalyst driving the rally The quantum computing company trades at 2,293 times sales with just $7.5 million

IonQ Stock Pops 11% on Monday Despite Insiders Heading for the Exit

TLDR

  • IonQ stock jumped 10.9% on Monday with no clear news catalyst driving the rally
  • The quantum computing company trades at 2,293 times sales with just $7.5 million in trailing revenue
  • Analysts maintain mixed ratings with nine Buys, seven Holds, and one Sell rating
  • The company reported a massive loss of $3.58 per share last quarter, missing estimates by $3.14
  • IonQ isn’t expected to turn profitable until at least 2031, even with projected revenue of $1.5 billion by 2030

IonQ shares climbed 11% on Monday, closing at $53.86 with trading volume of 28.7 million shares. That’s above the average daily volume of 24.2 million shares.


IONQ Stock Card
IonQ, Inc., IONQ

The rally came without any obvious news. No new contracts, no product announcements, no analyst upgrades on the day itself.

Market watchers pointed to general enthusiasm around quantum computing stocks in 2025. But that explanation feels thin when you dig into the numbers.

IonQ’s year-to-date performance tells a different story than the quantum hype suggests. The stock is up just 17% for the year. That barely beats the S&P 500’s 14% gain over the same period.

Valuation Concerns Mount

The company holds the title of largest pure-play quantum computing stock by market cap at $18.7 billion. But the fundamentals tell a rougher story.

IonQ generated only $7.5 million in revenue over the past 12 months. That creates a price-to-sales ratio of 2,293.

The company has no P/E ratio because it has no earnings. Last quarter’s results showed a loss of $3.58 per share, missing analyst estimates by a wide margin.

Revenue did grow 221.5% year-over-year to $39.9 million in the most recent quarter. That beat expectations of $27 million. But the company’s net margin sits at negative 1,836%.

Analyst sentiment remains mixed. Nine analysts rate the stock a Buy, seven say Hold, and one recommends Sell. The consensus price target of $72.08 suggests upside from current levels.

Wall Street Revisions

Recent price target changes show some optimism. B. Riley boosted its target from $75 to $100 in September. Mizuho initiated coverage in December with a $90 target and an Outperform rating.

Benchmark raised its target to $75, while Wedbush started coverage at $60. DA Davidson moved from $35 to $55 but kept a Neutral rating.

Analysts don’t expect profitability anytime soon. Projections show the company could hit $1.5 billion in sales by 2030 and still lose money. Even 2031 looks questionable for reaching the black.

Insider activity raised eyebrows recently. Director Kathryn Chou sold 20,000 shares at $51.40 in December. Chief Revenue Officer Rima Alameddine dumped 100,000 shares at $46.89 in November.

Institutional investors tell a mixed story. Amazon bought a new position worth $36.7 million in the second quarter. Norway’s sovereign wealth fund, Norges Bank, acquired $114.8 million worth of shares.

The stock trades above its 200-day moving average of $50.05. The 52-week range stretches from $17.88 to $84.64, showing the volatility investors face.

IonQ’s beta of 2.62 means it moves more than twice as much as the broader market. Monday’s pop fits that pattern, even without news to justify it.

The post IonQ Stock Pops 11% on Monday Despite Insiders Heading for the Exit appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.